Greenberg Steven, Murphy Glenn S, Avram Michael J, Shear Torin, Benson Jessica, Parikh Kruti N, Patel Aashka, Newmark Rebecca, Patel Vimal, Bailes Julian, Szokol Joseph W
Department of Anesthesiology, NorthShore University HealthSystem, Evanston and University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.
Department of Anesthesiology, NorthShore University HealthSystem, Evanston and University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.
World Neurosurg. 2018 Jan;109:e554-e562. doi: 10.1016/j.wneu.2017.10.021. Epub 2017 Oct 16.
To determine whether opioids during the first 24 postoperative hours were significantly altered when receiving intravenous (IV) acetaminophen during that time compared with those receiving placebo (normal saline).
One hundred forty patients undergoing any type of craniotomy were randomly assigned to receive either 1 g of IV acetaminophen or placebo upon surgical closure, and every 6 hours thereafter, up to 18 hours postoperatively. Analgesic requirements for the first 24 postoperative hours were recorded. Time to rescue medications in the postanesthesia care unit (PACU)/intensive care unit (ICU), amount of rescue medication, ICU and hospital lengths of stay, number of successful neurological examinations, sedation, delirium, satisfaction, and visual analog scale pain scores were also recorded.
Compared with the placebo group, more patients in the IV acetaminophen group (10/66 [15.2%] vs. 4/65 [6.2%] in the placebo group) did not require opioids within the first 24 postoperative hours, but this did not reach significance (odds ratio, -9.0%, 95% confidence interval -20.5% to 1.8%; P = 0.166). Both groups had similar times to rescue medications, amounts of rescue medications, ICU and hospital lengths of stay, numbers of successful neurological examinations, sedation, delirium, satisfaction scores, visual analog scale pain scores, and temperatures within the first 24 postoperative hours.
The opioid requirements within the first 24 postoperative hours were similar in the placebo and acetaminophen groups. This study is informative for the design and planning of future studies investigating the management of postoperative pain in patients undergoing craniotomies.
确定与接受安慰剂(生理盐水)的患者相比,术后24小时内接受静脉注射对乙酰氨基酚的患者,其阿片类药物的使用是否有显著变化。
140例接受任何类型开颅手术的患者在手术结束时被随机分配接受1g静脉注射对乙酰氨基酚或安慰剂,术后每6小时一次,直至术后18小时。记录术后24小时内的镇痛需求。还记录了在麻醉后护理单元(PACU)/重症监护病房(ICU)使用急救药物的时间、急救药物的用量、ICU和住院时间、成功的神经学检查次数、镇静情况、谵妄、满意度以及视觉模拟评分疼痛评分。
与安慰剂组相比,静脉注射对乙酰氨基酚组更多患者(10/66 [15.2%] 对比安慰剂组的4/65 [6.2%])在术后24小时内不需要使用阿片类药物,但这未达到显著差异(优势比,-9.0%,95%置信区间 -20.5%至1.8%;P = 0.166)。两组在术后24小时内使用急救药物的时间、急救药物的用量、ICU和住院时间、成功的神经学检查次数、镇静情况、谵妄、满意度评分、视觉模拟评分疼痛评分以及体温方面均相似。
安慰剂组和对乙酰氨基酚组术后24小时内的阿片类药物需求相似。本研究为未来研究开颅手术患者术后疼痛管理的设计和规划提供了参考信息。